Strides Pharma Science Q3 net slips 69 per cent to Rs 92 crore
The drug firm had posted consolidated profit of Rs 296.43 crore in the year-ago period.
The drug firm had posted consolidated profit of Rs 296.43 crore in the year-ago period.